
Manufacturers will have to carefully monitor performance of their 3PLs as more than half of the products in the pharma supply chain will be temperature-sensitive in the near future, says Phil Evans, director of sales, North America, TSS North America Inc. [Run Time (Min.): 6:40]











![Cover [e Book]](https://p1-cms-assets.imgix.net/files/base/keller/all/image/2026/10/scb.Cover-[E-book].jpg?ar=3%3A2&auto=format%2Ccompress&bg=fff&fill-color=fff&fit=fill&h=167&q=70&w=250)






